What is INmune Bio Inc. Common stock's Market Cap?

INmune Bio Inc. Common stock's Market Cap is $69.7M, based on as-reported figures from SEC (XBRL) filings.

What is INmune Bio Inc. Common stock's Enterprise Value?

INmune Bio Inc. Common stock's Enterprise Value is $56.9M, based on as-reported figures from SEC (XBRL) filings.

What is INmune Bio Inc. Common stock's Price / Sales?

INmune Bio Inc. Common stock's Price / Sales is 1393.2×, based on as-reported figures from SEC (XBRL) filings.

What is INmune Bio Inc. Common stock's EV / Revenue?

INmune Bio Inc. Common stock's EV / Revenue is 1138.6×, based on as-reported figures from SEC (XBRL) filings.

What is INmune Bio Inc. Common stock's Revenue (TTM)?

INmune Bio Inc. Common stock's Revenue (TTM) is $50.0K, based on as-reported figures from SEC (XBRL) filings.

What is INmune Bio Inc. Common stock's Net Income (TTM)?

INmune Bio Inc. Common stock's Net Income (TTM) is -$49.9M, based on as-reported figures from SEC (XBRL) filings.

What is INmune Bio Inc. Common stock's Diluted EPS (TTM)?

INmune Bio Inc. Common stock's Diluted EPS (TTM) is -1.80, based on as-reported figures from SEC (XBRL) filings.

What is INmune Bio Inc. Common stock's Net Debt?

INmune Bio Inc. Common stock's Net Debt is -$12.7M, based on as-reported figures from SEC (XBRL) filings.

INmune Bio Inc. Common stock (INMB) Financial Statements

INmune Bio Inc. Common stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00LW94M14

XNAS · usd

2.51▲ 0.07 (2.87%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close2.44

Day's Range2.41 – 2.60

52-Week Range1.09 – 2.60

Volume492.4K

Avg Volume335.3K

Share Statistics

Shares Outstanding

Employees21

ExchangeXNAS

Listed2019-02-04

Share count as of August 6, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about INmune Bio Inc. Common stock (INMB)

What is INmune Bio Inc. Common stock's Market Cap?: INmune Bio Inc. Common stock's Market Cap is $69.7M, based on as-reported figures from SEC (XBRL) filings.
What is INmune Bio Inc. Common stock's Enterprise Value?: INmune Bio Inc. Common stock's Enterprise Value is $56.9M, based on as-reported figures from SEC (XBRL) filings.
What is INmune Bio Inc. Common stock's Price / Sales?: INmune Bio Inc. Common stock's Price / Sales is 1393.2×, based on as-reported figures from SEC (XBRL) filings.
What is INmune Bio Inc. Common stock's EV / Revenue?: INmune Bio Inc. Common stock's EV / Revenue is 1138.6×, based on as-reported figures from SEC (XBRL) filings.
What is INmune Bio Inc. Common stock's Revenue (TTM)?: INmune Bio Inc. Common stock's Revenue (TTM) is $50.0K, based on as-reported figures from SEC (XBRL) filings.
What is INmune Bio Inc. Common stock's Net Income (TTM)?: INmune Bio Inc. Common stock's Net Income (TTM) is -$49.9M, based on as-reported figures from SEC (XBRL) filings.
What is INmune Bio Inc. Common stock's Diluted EPS (TTM)?: INmune Bio Inc. Common stock's Diluted EPS (TTM) is -1.80, based on as-reported figures from SEC (XBRL) filings.
What is INmune Bio Inc. Common stock's Net Debt?: INmune Bio Inc. Common stock's Net Debt is -$12.7M, based on as-reported figures from SEC (XBRL) filings.